110TiPA phase I dose escalation trial evaluating the impact of an in situ immunization strategy with intra-tumoral injections of Pexa-Vec in combination with ipilimumab in advanced solid tumors with injectable lesions. (17th December 2018) - Marabelle, A; Eberst, L; Terret, C; Pilleul, F; Mastier, C; Bouhamama, A; Gilles-Afchain, L; Laurent, S; Delzano, I; Reynaud, C; Caux, C; Caux, C; et al.